Novo Nordisk Plans Price Cuts for Several Insulins

March 14, 2023by Tom Murphy, Associated Press
Novo Nordisk Plans Price Cuts for Several Insulins
This Wednesday, March 1, 2023, photo shows a vial of Eli Lilly's Humalog insulin in New York. Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on costs they pay to fill prescriptions. (AP Photo/Pablo Salinas)

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly.

The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30.

Novo also will drop the list price of unbranded products like Insulin Aspart to match the lower price of the branded insulins.

The price cuts go into effect Jan. 1. A vial of NovoLog and NovoLog Mix 70/30 will drop 75% to $72.34 from $289.36. FlexPen options will fall to $139.71 from more than $500.


Levemir and Novolin vials and FlexPens will drop 65% from their current list prices.

Eli Lilly and Co. said March 2 that it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% or more in the fourth quarter, which starts in October.

List prices are what a drugmaker initially sets for a product and what people who have no insurance or plans with high deductibles are sometimes stuck paying.


Patient advocates have long called for insulin price cuts to help uninsured people who would not be affected by price caps tied to insurance coverage. They have noted that high insulin prices force many people to ration doses, which can be dangerous for their health.

Research has shown that prices for insulin have more than tripled in the last two decades. Pressure is growing on drugmakers to help patients.

Major insulin makers like Lilly and Novo have said they offer patient assistance programs and other help. But Lilly CEO David Ricks noted earlier this month that discounts the drugmaker offers from its list prices often don’t reach patients through insurers or pharmacy benefit managers.

The federal government in January started applying a $35 cap on monthly out-of-pocket costs to patients with coverage through its Medicare program for people age 65 and older or those who have certain disabilities or illnesses.

Insulin is made by the pancreas and used by the body to convert food into energy. People who have diabetes don’t produce enough insulin. Those with Type 1 diabetes must take insulin every day to survive.


More than 8 million Americans use insulin, according to the American Diabetes Association.

The Wall Street Journal first reported the price cuts Tuesday morning.

A+
a-

In The News

Health

Voting

Health

May 25, 2023
by Dan McCue
Administration Floats New Rules for Drug Cost Transparency

WASHINGTON — The Biden administration has proposed using new tools to monitor costs associated with prescription drugs so it can... Read More

WASHINGTON — The Biden administration has proposed using new tools to monitor costs associated with prescription drugs so it can hold pharma manufacturers accountable for what Medicaid programs pay for them. The Notice of Proposed Rule Making was made through the Department of Health and Human... Read More

May 24, 2023
by Dan McCue
Fourth Death Attributed to Recalled Artificial Tears

ATLANTA — A fourth death has been linked to a recalled brand of artificial tears made by EzriCare and Delsam... Read More

ATLANTA — A fourth death has been linked to a recalled brand of artificial tears made by EzriCare and Delsam Pharma, as the number of infections with a highly drug-resistant bacteria grew to 81 across 18 states, the Centers for Disease Control and Prevention reports. The... Read More

May 24, 2023
by Dan McCue
New Study Finds Strong Legs Could Be Key to Strong Heart

PRAGUE, Czechia — Patients with especially strong legs are less likely to develop heart failure following a heart attack, according... Read More

PRAGUE, Czechia — Patients with especially strong legs are less likely to develop heart failure following a heart attack, according to a new report from the European Society of Cardiology. Myocardial infarction (a heart attack) is the most common cause of heart failure, with roughly 6%-9%... Read More

May 24, 2023
by Dan McCue
Panel Says Jury Still Out on Oral Screening by Primary Care Providers

WASHINGTON — An independent panel of health care experts said Tuesday that there’s simply not enough evidence to recommend for... Read More

WASHINGTON — An independent panel of health care experts said Tuesday that there’s simply not enough evidence to recommend for or against oral health screening being done by primary health care providers. The U.S. Preventive Services Task Force has been considering making a recommendation on oral... Read More

May 24, 2023
by Dan McCue
Surgeon General Warns Social Media Poses ‘Profound Risk’ to Young People

WASHINGTON — While social media use may be beneficial to some people, the U.S. surgeon general warned Tuesday that not... Read More

WASHINGTON — While social media use may be beneficial to some people, the U.S. surgeon general warned Tuesday that not enough is being done to fully understand or address the likely harm it does to the mental health and well-being of children and young adults. Dr.... Read More

May 23, 2023
by TWN Staff
Patients, Caregivers Blame Themselves and Each Other for Home-Based Care Lapses

NEW YORK — “Broken” home-based health care experiences are causing avoidable hospital readmissions, exacting worrisome financial and psychological tolls on... Read More

NEW YORK — “Broken” home-based health care experiences are causing avoidable hospital readmissions, exacting worrisome financial and psychological tolls on patients and caregivers alike, a new survey by Tomorrow Health has found. According to the American Hospital Association, 35 million Americans were hospitalized in 2022, with... Read More

News From The Well
scroll top